Loss of SHROOM2 enhances NPC cell migration, invasion, and metastatic potential, while also promoting epithelial-to-mesenchymal transition (EMT) (Yuan et al., 2019), thereby facilitating NPC progression. This evidence concerns the gene SHROOM2 and nasopharyngeal carcinoma.